Fanni Natanegara

610 total citations
30 papers, 460 citations indexed

About

Fanni Natanegara is a scholar working on Psychiatry and Mental health, Clinical Psychology and Statistics and Probability. According to data from OpenAlex, Fanni Natanegara has authored 30 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 8 papers in Clinical Psychology and 8 papers in Statistics and Probability. Recurrent topics in Fanni Natanegara's work include Sexual function and dysfunction studies (9 papers), Sexuality, Behavior, and Technology (8 papers) and Statistical Methods in Clinical Trials (8 papers). Fanni Natanegara is often cited by papers focused on Sexual function and dysfunction studies (9 papers), Sexuality, Behavior, and Technology (8 papers) and Statistical Methods in Clinical Trials (8 papers). Fanni Natanegara collaborates with scholars based in United States, United Kingdom and Singapore. Fanni Natanegara's co-authors include Sanjeev Ahuja, David G. Wong, Sergey Shcherbinin, Brian A. Willis, Stephen L. Lowe, John R. Sims, Laiyi Chua, Paul Ardayfio, Nagy A. Farid and David S. Small and has published in prestigious journals such as Nature Reviews Drug Discovery, The Journal of Urology and Psychopharmacology.

In The Last Decade

Fanni Natanegara

30 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fanni Natanegara United States 13 172 113 104 81 72 30 460
Rebecca N Gray United States 14 229 1.3× 93 0.8× 74 0.7× 228 2.8× 39 0.5× 22 847
Oliver Langford United States 14 263 1.5× 34 0.3× 168 1.6× 44 0.5× 20 0.3× 27 579
Beverley Patterson United Kingdom 6 173 1.0× 115 1.0× 33 0.3× 38 0.5× 43 0.6× 6 366
Donald J. Nichols United Kingdom 6 150 0.9× 79 0.7× 19 0.2× 158 2.0× 28 0.4× 7 478
Elizabeth S. Duke United States 10 145 0.8× 47 0.4× 42 0.4× 32 0.4× 9 0.1× 23 666
Sebastian Ueckert Sweden 11 57 0.3× 43 0.4× 44 0.4× 20 0.2× 5 0.1× 34 461
Arne Risselada Netherlands 14 145 0.8× 64 0.6× 37 0.4× 41 0.5× 21 0.3× 29 573
Bernard Esquivel United States 5 60 0.3× 21 0.2× 32 0.3× 33 0.4× 11 0.2× 8 467
Tamara Božina Croatia 12 67 0.4× 34 0.3× 48 0.5× 37 0.5× 10 0.1× 34 312
Zhengyang Zhou United States 15 21 0.1× 19 0.2× 59 0.6× 32 0.4× 29 0.4× 67 689

Countries citing papers authored by Fanni Natanegara

Since Specialization
Citations

This map shows the geographic impact of Fanni Natanegara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanni Natanegara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanni Natanegara more than expected).

Fields of papers citing papers by Fanni Natanegara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fanni Natanegara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanni Natanegara. The network helps show where Fanni Natanegara may publish in the future.

Co-authorship network of co-authors of Fanni Natanegara

This figure shows the co-authorship network connecting the top 25 collaborators of Fanni Natanegara. A scholar is included among the top collaborators of Fanni Natanegara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fanni Natanegara. Fanni Natanegara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Welsh‐Bohmer, Kathleen A., Geoffrey A. Kerchner, Shobha Dhadda, et al.. (2023). Decision making in clinical trials: Interim analyses, innovative design, and biomarkers. Alzheimer s & Dementia Translational Research & Clinical Interventions. 9(4). e12421–e12421. 1 indexed citations
2.
Singh, Pritibha, Andrea M. Burden, Fanni Natanegara, & Robert A. Beckman. (2023). Design and Execution of Sustainable Decentralized Clinical Trials. Clinical Pharmacology & Therapeutics. 114(4). 802–809. 9 indexed citations
3.
Bray, Ross, A. Hartley, Deborah Wenkert, et al.. (2022). Why are There not More Bayesian Clinical Trials? Ability to Interpret Bayesian and Conventional Statistics Among Medical Researchers. Therapeutic Innovation & Regulatory Science. 57(3). 426–435. 3 indexed citations
4.
Natanegara, Fanni, A. Hartley, Deborah Wenkert, et al.. (2022). Why are not There More Bayesian Clinical Trials? Perceived Barriers and Educational Preferences Among Medical Researchers Involved in Drug Development. Therapeutic Innovation & Regulatory Science. 57(3). 417–425. 15 indexed citations
5.
Lo, Albert, Cynthia Evans, Michele Mancini, et al.. (2021). Phase II (NAVIGATE-AD study) Results of LY3202626 Effects on Patients with Mild Alzheimer’s Disease Dementia. Journal of Alzheimer s Disease Reports. 5(1). 321–336. 22 indexed citations
6.
Kielbasa, William, Krista M Phipps, Fanni Natanegara, et al.. (2020). A single ascending dose study in healthy volunteers to assess the safety and PK of LY3372689, an inhibitor of O‐GlcNAcase (OGA) enzyme. Alzheimer s & Dementia. 16(S9). 9 indexed citations
7.
Natanegara, Fanni, Névine Zariffa, Joan Buenconsejo, et al.. (2020). Statistical Opportunities to Accelerate Development for COVID-19 Therapeutics. Statistics in Biopharmaceutical Research. 14(1). 5–21. 6 indexed citations
8.
Hess, Lisa M., Amy M. DeLozier, Fanni Natanegara, et al.. (2018). First-line treatment of patients with advanced or metastatic squamous non-small cell lung cancer: systematic review and network meta-analysis. Journal of Thoracic Disease. 10(12). 6677–6694. 5 indexed citations
9.
DeLozier, Amy M., Jacqueline Brown, Fanni Natanegara, et al.. (2014). Study protocol: systematic review and meta-analysis of randomized controlled trials in first-line treatment of squamous non-small cell lung cancer. Systematic Reviews. 3(1). 3 indexed citations
10.
Stamey, James D., Fanni Natanegara, & John W. Seaman. (2013). Bayesian Sample Size Determination for a Clinical Trial with Correlated Continuous and Binary Outcomes. Journal of Biopharmaceutical Statistics. 23(4). 790–803. 6 indexed citations
11.
Kelly, Ronan P., Sandra Close, Nagy A. Farid, et al.. (2011). Pharmacokinetics and pharmacodynamics following maintenance doses of prasugrel and clopidogrel in Chinese carriers of CYP2C19 variants. British Journal of Clinical Pharmacology. 73(1). 93–105. 42 indexed citations
12.
Lowe, Stephen L., Robert A. Dean, Bradley L. Ackermann, et al.. (2011). Effects of a novel mGlu2/3 receptor agonist prodrug, LY2140023 monohydrate, on central monoamine turnover as determined in human and rat cerebrospinal fluid. Psychopharmacology. 219(4). 959–970. 9 indexed citations
13.
Small, David S., Christopher D. Payne, Prajakti A. Kothare, et al.. (2010). Pharmacodynamics and pharmacokinetics of single doses of prasugrel 30 mg and clopidogrel 300 mg in healthy chinese and white volunteers: An open-label trial. Clinical Therapeutics. 32(2). 365–379. 39 indexed citations
14.
Shabsigh, Ridwan, Gregory A. Broderick, Stanley E. Althof, Fanni Natanegara, & David G. Wong. (2009). Daily patterns of sexual intercourse attempts by men with erectile dysfunction treated with tadalafil: influence of age and marital status. International Journal of Impotence Research. 21(5). 285–291. 5 indexed citations
15.
Shabsigh, Ridwan, R. Rosen, Rajesh Shinghal, et al.. (2008). Response to treatment with tadalafil in men with erectile dysfunction who reported no successful intercourse attempts at baseline. International Journal of Impotence Research. 20(6). 554–560. 5 indexed citations
16.
17.
18.
19.
Althof, Stanley E., J. François Eid, David Talley, et al.. (2006). Through the eyes of women: The partners’ perspective on tadalafil. Urology. 68(3). 631–635. 29 indexed citations
20.
Shabsigh, Ridwan, Arthur L. Burnett, Ian Eardley, et al.. (2005). Time from dosing to sexual intercourse attempts in men taking tadalafil in clinical trials. British Journal of Urology. 96(6). 857–863. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rebecca N Gray Breakdown of academic impact, for papers by Oliver Langford Breakdown of academic impact, for papers by Beverley Patterson Breakdown of academic impact, for papers by Donald J. Nichols Breakdown of academic impact, for papers by Elizabeth S. Duke Breakdown of academic impact, for papers by Sebastian Ueckert Breakdown of academic impact, for papers by Arne Risselada Breakdown of academic impact, for papers by Bernard Esquivel Breakdown of academic impact, for papers by Tamara Božina Breakdown of academic impact, for papers by Zhengyang Zhou
Rankless by CCL
2026